Suppr超能文献

纳米颗粒技术与干细胞疗法联手对抗神经退行性疾病。

Nanoparticle technology and stem cell therapy team up against neurodegenerative disorders.

机构信息

The Biochemistry, Cellular and Molecular Biology Graduate Program, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Department of Neuroscience and Mahoney Institute for Neurosciences, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104, USA; The Institute for Regenerative Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

Adv Drug Deliv Rev. 2019 Aug;148:239-251. doi: 10.1016/j.addr.2019.02.007. Epub 2019 Feb 21.

Abstract

The convergence of nanoparticles and stem cell therapy holds great promise for the study, diagnosis, and treatment of neurodegenerative disorders. Researchers aim to harness the power of nanoparticles to regulate cellular microenvironment, improve the efficiency of cell and drug delivery to the brain, and enhance the survival of stem cell transplants. Understanding the various properties of different nanoparticles is key to applying them to clinical therapies; the many distinct types of nanoparticles offer unique capacities for medical imaging, diagnosis, and treatment of neurodegeneration disorders. In this review we introduce the biology of Alzheimer's, Parkinson's Disease, and amyotrophic lateral sclerosis, and discuss the potentials and shortcomings of metal, silica, lipid-based, polymeric, and hydrogel nanoparticles for diagnosis and treatment of neurodegenerative disorders. We then provide an overview of current strategies in stem cell therapies and how they can be combined with nanotechnology to improve clinical outcomes.

摘要

纳米粒子与干细胞疗法的结合为神经退行性疾病的研究、诊断和治疗带来了巨大的希望。研究人员旨在利用纳米粒子的力量来调节细胞微环境,提高细胞和药物向大脑输送的效率,并增强干细胞移植的存活率。了解不同纳米粒子的各种特性是将其应用于临床治疗的关键;许多不同类型的纳米粒子为神经退行性疾病的医学成像、诊断和治疗提供了独特的能力。在这篇综述中,我们介绍了阿尔茨海默病、帕金森病和肌萎缩侧索硬化症的生物学,并讨论了金属、硅、脂质基、聚合物和水凝胶纳米粒子在神经退行性疾病的诊断和治疗方面的潜力和局限性。然后,我们概述了干细胞疗法的当前策略以及如何将其与纳米技术结合以改善临床结果。

相似文献

1
Nanoparticle technology and stem cell therapy team up against neurodegenerative disorders.
Adv Drug Deliv Rev. 2019 Aug;148:239-251. doi: 10.1016/j.addr.2019.02.007. Epub 2019 Feb 21.
2
Application of Nanocomposites and Nanoparticles in Treating Neurodegenerative Disorders.
CNS Neurol Disord Drug Targets. 2024;23(10):1217-1233. doi: 10.2174/0118715273283338240104112106.
3
Potential Gene Therapy Towards Treating Neurodegenerative Disea ses Employing Polymeric Nanosystems.
Curr Gene Ther. 2017;17(2):170-183. doi: 10.2174/1566523217666170510153845.
4
Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine.
Int J Mol Sci. 2014 Mar 4;15(3):3904-25. doi: 10.3390/ijms15033904.
5
Novel nanomaterials for clinical neuroscience.
J Neuroimmune Pharmacol. 2008 Jun;3(2):83-94. doi: 10.1007/s11481-007-9099-6. Epub 2008 Jan 22.
6
Nanoparticles approaches in neurodegenerative diseases diagnosis and treatment.
Neurol Sci. 2021 Jul;42(7):2653-2660. doi: 10.1007/s10072-021-05234-x. Epub 2021 Apr 12.
7
Neurotheranostics as personalized medicines.
Adv Drug Deliv Rev. 2019 Aug;148:252-289. doi: 10.1016/j.addr.2018.10.011. Epub 2018 Oct 26.
9
Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
Eur J Pharm Biopharm. 2020 Apr;149:192-217. doi: 10.1016/j.ejpb.2020.01.005. Epub 2020 Jan 23.
10

引用本文的文献

2
Harnessing nanotechnology for stem-cell therapies: revolutionizing neurodegenerative disorder treatments - a state-of-the-art update.
Front Pharmacol. 2025 Jul 23;16:1630475. doi: 10.3389/fphar.2025.1630475. eCollection 2025.
4
Single-Atom Colloidal Nanorobotics Enhanced Stem Cell Therapy for Corneal Injury Repair.
ACS Nano. 2025 May 27;19(20):19095-19115. doi: 10.1021/acsnano.4c18874. Epub 2025 May 13.
7
Applications of Gene Editing and Nanotechnology in Stem Cell-Based Therapies for Human Diseases.
Stem Cell Rev Rep. 2025 Feb 27. doi: 10.1007/s12015-025-10857-0.
8
Advances in hydrogel for diagnosis and treatment for Parkinson's disease.
Front Pharmacol. 2025 Feb 12;16:1552586. doi: 10.3389/fphar.2025.1552586. eCollection 2025.
10
Stem cell transplantation therapy for advanced liver damage-associated neurodegenerative disorders.
Int J Surg. 2024 Nov 1;110(11):6873-6882. doi: 10.1097/JS9.0000000000002001.

本文引用的文献

1
Allogeneic Mesenchymal Stem Cells and Biomaterials: The Perfect Match for Cardiac Repair?
Int J Mol Sci. 2018 Oct 19;19(10):3236. doi: 10.3390/ijms19103236.
2
Nanogels as potential drug nanocarriers for CNS drug delivery.
Drug Discov Today. 2018 Jul;23(7):1436-1443. doi: 10.1016/j.drudis.2018.05.018. Epub 2018 May 20.
3
Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.
Prog Neurobiol. 2018 Sep;168:1-20. doi: 10.1016/j.pneurobio.2018.04.005. Epub 2018 Apr 11.
5
Human Hippocampal Neurogenesis Persists throughout Aging.
Cell Stem Cell. 2018 Apr 5;22(4):589-599.e5. doi: 10.1016/j.stem.2018.03.015.
6
Polymeric Nanoparticles for Increasing Oral Bioavailability of Curcumin.
Antioxidants (Basel). 2018 Mar 24;7(4):46. doi: 10.3390/antiox7040046.
8
Nanomaterials in Neural-Stem-Cell-Mediated Regenerative Medicine: Imaging and Treatment of Neurological Diseases.
Adv Mater. 2018 Apr;30(17):e1705694. doi: 10.1002/adma.201705694. Epub 2018 Mar 15.
9
Questioning human neurogenesis.
Nature. 2018 Mar 15;555(7696):315-316. doi: 10.1038/d41586-018-02629-3.
10
Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults.
Nature. 2018 Mar 15;555(7696):377-381. doi: 10.1038/nature25975. Epub 2018 Mar 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验